Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 28th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 78% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 28th, 2024 04:08PM | Apr 28th, 2024 04:08PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 26th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 78% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 8.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 26th, 2024 07:54AM | Apr 26th, 2024 07:54AM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 25th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 78% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 25th, 2024 06:10PM | Apr 25th, 2024 06:10PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 24th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 78% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 0.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 24th, 2024 10:38AM | Apr 24th, 2024 10:38AM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 23rd, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 78% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 0.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 23rd, 2024 04:12PM | Apr 23rd, 2024 04:12PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 21st, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 79% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 5.00 | 13.00 | 21.00 | 26.00 | 23.00 | 9.524% | 4.762% | 23.81% | 61.905% | 26.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 21st, 2024 04:15PM | Apr 21st, 2024 04:15PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 20th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 79% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 6.00 | 13.00 | 22.00 | 26.00 | 23.00 | 9.091% | 4.545% | 27.273% | 59.091% | 26.00 | 0.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 20th, 2024 04:30PM | Apr 20th, 2024 04:30PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 19th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 79% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 6.00 | 13.00 | 22.00 | 26.00 | 23.00 | 9.091% | 4.545% | 27.273% | 59.091% | 26.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 19th, 2024 07:27AM | Apr 19th, 2024 07:27AM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | ||||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 18th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 79% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 6.00 | 13.00 | 22.00 | 26.00 | 23.00 | 9.091% | 4.545% | 27.273% | 59.091% | 26.00 | 0.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 18th, 2024 05:50PM | Apr 18th, 2024 05:50PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:bpmc | https://www.glassdoor.com?employer_id=719381 | 719381 | Apr 17th, 2024 12:00AM | Open | Blueprint Medicines | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2011 | 4.20 | 94% | 79% | 85% | 4.50 | 4.40 | 4.00 | 4.40 | 3.90 | 4.10 | 2.00 | 1.00 | 6.00 | 13.00 | 22.00 | 26.00 | 23.00 | 9.091% | 4.545% | 27.273% | 59.091% | 26.00 | 54.00 | 0.46 | 0.21 | 0.32 | 0.65 | 0.24 | 0.12 | Kate Haviland | Apr 17th, 2024 02:17PM | Apr 17th, 2024 02:17PM | Blueprint Medicines | Health Care | Pharmaceuticals & Biotechnology |